Antiviral Drugs Market Size

Antiviral Drugs Market Size

Antiviral Drugs Market size crossed USD 48 billion in 2021 and is expected to progress at 3.4% CAGR through 2028 due to the higher incidence rate of infectious diseases. The growing prevalence of HIV infections across the globe is one of the dominant factors influencing the demand for antiviral drugs.

To get key market trends

  Download Free Sample

For instance, according to the U.S. Department of Health & Human Services and Minority HIV/AIDS Fund, in 2020, around 37.7 million individuals with HIV infections were reported across the globe. Thus, increasing product accessibility in developed countries for advanced treatments, including antiretroviral therapy, to cater disease burden will propel the overall antiviral drugs market growth.

Further, as per the World Health Organization’s data in 2019, over 1.5 million new cases with hepatitis B infection are reported every year and nearly 296 million individuals were estimated to be infected with chronic hepatitis B across the world. Therefore, the rising incidence rate of several other infectious diseases such as herpes simplex virus, hepatitis virus, and influenza will stimulate the market revenue.
    

The COVID-19 pandemic has positively impacted the product sales of antiviral drugs. Sudden spike in the number of COVID-19 cases and primary focus of healthcare facilities on the treatment of COVID-19 patients has stimulated the market growth. Moreover, numerous pharmaceutical companies were focusing on new drug development for effective treatment and better patient outcomes. These companies were also collaborating to cater product demand throughout the period.
 

For instance, in May 2020, Cipla Inc. partnered with Gilead Sciences for manufacturing and distribution of remdesivir to treat COVID-19 patients in more than 127 countries. Therefore, proactive collaborations and strategic efforts by market players to broaden their manufacturing capacities antiviral drugs for catering to a large patient base have fuelled the overall antiviral drugs market share.
 

Antiviral drugs are the class of medicines that are used to treat viral infections such as hepatitis, HIV and influenza among others. These drugs are prescribed in the forms of tablet, liquid, injectable solution and inhaled powders. Antiviral drugs are used to eradicate disease causing viruses from the body. There are certain types of antiviral medications available in the market such as protease inhibitors, reverse transcriptase inhibitors (NRTIs and NNRTIs), neuraminidase inhibitors and DNA polymerase inhibitors.